Subscribe to RSS
DOI: 10.1055/s-0043-111235
Childhood Vaccination Against Seasonal Influenza to Reduce the Overall Burden of Disease: Ethical Perspectives
Impfung gegen saisonale Influenza im Kindesalter zur Reduktion der allgemeinen Krankheitslast – Ethische PerspektivenPublication History
Publication Date:
11 July 2017 (online)
Abstract
Introduction Childhood immunisation against seasonal influenza promises to reduce the burden of disease through herd immunity. The option of intranasal vaccination seemed to offer a more acceptable vaccination for children, as they are perceived to be less invasive. Yet, intranasal vaccines have been recently proven not to be as effective as presumed. In Germany, contradictory recommendations of the Standing Committee on Vaccination (STIKO) first, to use and then, in October 2016, not use these vaccines have been issued for the 2016–2017 season, whereas recommendations not to use them were already issued in the USA (CDC, ACIP). This controversy spurs the discussion of immunisation programmes for children again. Despite studies discussing the effectiveness of a comprehensive immunisation programme targeting children also in the German and wider European context, an accompanying ethical discussion is missing.
Methodology We discuss several policy options from different key ethical perspectives that are widely used in public health: if seasonal influenza vaccination should be intensively offered to or even made mandatory for children to decrease the societal burden of the disease.
Results Various ethical perspectives reflect the question how to balance individual autonomy, personal benefit and population benefit differently.
Discussion A convincing justification for suggestions on immunisation policies has to balance norms anchored in different ethical theories. There are good reasons to offer immunisation programmes against seasonal influenza to children, using a voluntary, possibly incentive-based approach.
Zusammenfassung
Ziel der Studie Die Impfung von Kindern gegen saisonale Influenza um möglichst Herdimmunität zu erreichen, könnte die allgemeine Krankheitslast verringern und wird international diskutiert. Nasale Impfstoffe bieten eine neue Methode, die als sanfter empfunden werden könnte und somit potenziell akzeptabler für Kinder und Eltern erscheinen könnte. Allerdings haben sich diese Impfstoffe in jüngster Zeit als nicht so effektiv herausgestellt, wie erhofft. So gab es für die Grippe-Impfsaison 2016/2017 von der STIKO schon 2 verschiedene Empfehlungen, zuerst, die Impfung mit dem nasalen Impfstoff durchzuführen und, ab Oktober 2016, sie doch nicht fortzuführen. Die aktuellen Entwicklungen befördern Diskussionen von Kinder-Impfprogrammen. Obwohl einzelne Studien die Effektivität umfassender Impfprogramme gegen saisonale Influenza bei Kindern in Deutschland und Europa diskutieren, fehlt die ethische Betrachtung des Themas.
Methodik Wir diskutieren aus ethischer Sicht mit Rückgriff auf zentrale und weithin im Bereich Public Health benutzte ethische Positionen, ob eine saisonale Influenzaimmunisierung im Kindesalter verstärkt angeboten werden oder sogar verpflichtend sein sollte, um die allgemeine Krankheitslast zu reduzieren.
Ergebnisse Bei der Anwendung diverser ethischer Perspektiven wird die Frage verschiedentlich beantwortet, wie man individuelle Autonomie, persönlichen und gesellschaftlichen Nutzen abwägen sollte.
Schlussfolgerungen Eine überzeugende und plausible Rechtfertigung von Impfpolitiken muss verschiedene ethische Normen berücksichtigen und abwägen. Es gibt gute Gründe, Kindern gezielt Impfprogramme zur saisonalen Influenzaprävention anzubieten. Die Impfungen sollten allerdings freiwillig bleiben. Gleichwohl könnte man Anreiz-orientierte Ansätze erwägen.
-
References
- 1 Nowak GJ, Sheedy K, Bursey K. et al. Promoting influenza vaccination: insights from a qualitative meta-analysis of 14 years of influenza-related communications research by U.S. Centers for Disease Control and Prevention (CDC). Vaccine 2015; 33: 2741-2756
- 2 Kieny MP, Costa A, Hombach J. et al. A global pandemic influenza vaccine action plan. Vaccine 2006; 24: 6367-6370
- 3 Reichert TA, Sugaya N, Fedson DS. et al. The Japanese experience with vaccinating schoolchildren against influenza. The New England journal of medicine 2001; 344: 889-896
- 4 Carter NJ, Curran MP. Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults. Drugs 2011; 71: 1591-1622
- 5 McGuire A, Drummond M. Keeping S. Childhood and adolescent influenza vaccination in Europe: A review of current policies and recommendations for the future. Expert review of vaccines 2016; 15: 659-670
- 6 Rose MA, Damm O, Greiner W. et al. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis 2014; 14: 40
- 7 Grohskopf LA, Sokolow LZ, Broder KR. et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2016; 65: 1-54
- 8 Der STIKO M. Stellungnahme der STIKO zur Anwendung von Influenza-Lebendimpfstoffen bei Kindern in der Saison 2016/2017. Epidemiologisches Bulletin 2016; 39
- 9 WHO. Guidance for managing ethical issues in infectious disease outbreaks. 2016
- 10 Daniels N. Justice and justification: Reflective equilibrium in theory and practice. Cambridge University Press; 1996
- 11 Stapleton G, Schroder-Back P, Brand H. et al. Health inequalities and regional specific scarcity in primary care physicians: ethical issues and criteria. Int J Public Health 2014; 59: 449-455
- 12 Holland S. Public health ethics. John Wiley & Sons; 2015
- 13 Capron AM. Ethical considerations in international preparedness planning efforts. In: Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. 2007
- 14 Faden R, Shebaya S. Public health ethics. 2016
- 15 Nuffield-Council-on-Bioethics. Public health: ethical issues: Nuffield Council on Bioethics. 2007
- 16 Willison DJ, Ondrusek N, Dawson A. et al. What makes public health studies ethical? Dissolving the boundary between research and practice. BMC Med Ethics 2014; 15: 61
- 17 Lee LM. Public health ethics theory: review and path to convergence. The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics 2012; 40: 85-98
- 18 Powers M, Faden RR. Social justice: the moral foundations of public health and health policy. Oxford University Press; USA: 2006
- 19 Miettinen OS. Idealism and ethics of public-health practitioners. Eur J Epidemiol 2005; 20: 805-807
- 20 Mackenbach J. Kos, Dresden, Utopia… A journey through idealism past and present in public health. Eur J Epidemiol. 2005; 20: 817-826
- 21 Mill JS. 1991. On liberty. On liberty and other essays, ed John Gray 1859: 5–128.
- 22 Bioethics NCO . Public Health: ethical issues. London, England: Nuffield Council; 2007
- 23 Dawson AJ. Snakes and ladders: state interventions and the place of liberty in public health policy. J Med Ethics 2016; 42: 510-513
- 24 Nozick R. Anarchy, state, and utopia: Basic books. 1974
- 25 Daniels N. Just Health: Meeting health needs fairly. In: Cambridge: Cambridge University Press; 2008
- 26 Nussbaum Martha C. Frontiers of justice: disability, nationality, species membership. In: Cambridge, Mass.: Belknap Press of Harvard University Press; 2006
- 27 West-Oram PG, Buyx A. Global health solidarity. Public Health Ethics 2016; phw021
- 28 Dawson A, Jennings B. The place of solidarity in public health ethics. Public Health Reviews 2012; 65-79
- 29 Veatch RM. Doctor does not know best: why in the new century physicians must stop trying to benefit patients. J Med Philos 2000; 25: 701-721
- 30 Thaler RH, Sunstein CR. Nudge: improving decisions about health, wealth, and happiness. 2008. Newhaven: Yale; 2009
- 31 Veatch RM. The ethics of promoting herd immunity. Fam Community Health 1987; 10: 44-53
- 32 Singer P. The most good you can do: how effective altruism is changing ideas about living ethically. Text Publishing; 2015
- 33 Field RI, Caplan AL. Evidence-based decision making for vaccines: the need for an ethical foundation. Vaccine 2012; 30: 1009-1013
- 34 O'Neill O. Public health or clinical ethics: thinking beyond borders. Ethics Int Aff 2002; 16: 35-45
- 35 Hein IM, Troost PW, Lindeboom R. et al. Feasibility of an assessment tool for children’s competence to consent to predictive genetic testing: a pilot study. Journal of genetic counseling 2015; 24: 971-977
- 36 Prainsack B, Buyx A. Solidarity in contemporary bioethics–towards a new approach. Bioethics 2012; 26: 343-350
- 37 van den Hoven M, Verweij M. Professional solidarity: the case of influenza immunization. The American Journal of Bioethics 2013; 13: 51-52
- 38 Wiesemann C. Moral Equality, Bioethics and the Child. Springer; 2016
- 39 Marckmann G, Schmidt H, Sofaer N. et al. Putting public health ethics into practice: a systematic framework. Frontiers in public health 2015; 3: 23
- 40 Schröder-Bäck P, Brand H, Escamilla I. et al. Ethical evaluation of compulsory measles immunisation as a benchmark for good health management in the European Union. Cent Eur J Public Health 2009; 17: 183
- 41 Constable C, Blank NR, Caplan AL. Rising rates of vaccine exemptions: problems with current policy and more promising remedies. Vaccine 2014; 32: 1793-1797
- 42 Wildner M. Propaganda, Nudging, Information. Das Gesundheitswesen 2016; 78: 357-358
- 43 Schröder-Bäck P, Martakis K. Counterpoint: should childhood vaccination against measles be a mandatory requirement for attending school?. No. CHEST Journal 2015; 148: 854-856